XML 249 R176.htm IDEA: XBRL DOCUMENT
v3.25.1

Reportable segments - Operating Segment Items (Details) - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Disclosure of operating segments [line items] |  |  |
Revenue | $ 4,528,761 | $ 7,467,490 | $ 10,710,578
Cost of sales | (3,201,654) | (4,392,436) | (4,973,953)
Administrative expenses | (185,959) | (175,765) | (142,644)
Finance expense | (197,544) | (138,402) | (86,651)
Depreciation and amortization expense | (342,424) | (280,787) | (244,458)
Interest in the income of associates and joint ventures accounted for by the equity method | 11,025 | 593 | 20,159
Income before taxes | 974,414 | 2,807,018 | 5,486,496
Income tax benefit (expense) | (282,573) | (1,876,751) | (1,572,212)
Net income | 691,841 | 930,267 | 3,914,284
Assets | 11,495,569 | 10,778,837 | 10,819,101
Investment accounted for under the equity method | 585,794 | 86,417 | 54,386
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | (1,181,113) | 2,785,385 | 1,757,581
Other Liabilities | 6,297,502 | 6,301,408 | 5,887,100
Impairment loss of non-financial assets recognized in income | (7,134) | (47,068) | (42,233)
Cash flows from (used in) operating activities | 1,274,678 | (196,639) | 4,077,595
Cash flows used in investing activities | (1,213,992) | (1,481,493) | (909,401)
Cash flows from (used in) financing activities | 282,383 | 66,261 | (2,002,969)
Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets | (639) | (202) | (3,369)
Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 4,528,761 | 7,467,490 | 10,710,578
Cost of sales | (3,201,654) | (4,392,436) | (4,973,953)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (342,424) | (280,787) | (244,458)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 1,327,107 | 3,075,054 | 5,736,625
Income tax benefit (expense) | 0 | 0 | 0
Net income | 1,327,107 | 3,075,054 | 5,736,625
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Operating segments | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets | 0 | 0 | 0
Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Cost of sales | 0 | 0 | 0
Administrative expenses | (185,959) | (175,765) | (142,644)
Finance expense | (197,544) | (138,402) | (86,651)
Depreciation and amortization expense | 0 | 0 | 0
Interest in the income of associates and joint ventures accounted for by the equity method | 11,025 | 593 | 20,159
Income before taxes | (352,693) | (268,036) | (250,129)
Income tax benefit (expense) | (282,573) | (1,876,751) | (1,572,212)
Net income | (635,266) | (2,144,787) | (1,822,341)
Assets | 11,495,569 | 10,778,837 | 10,819,101
Investment accounted for under the equity method | 585,794 | 86,417 | 54,386
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | (1,181,113) | 2,785,385 | 1,757,581
Other Liabilities | 6,297,502 | 6,301,408 | 5,887,100
Impairment loss of non-financial assets recognized in income | (7,134) | (47,068) | (42,233)
Cash flows from (used in) operating activities | 1,274,678 | (196,639) | 4,077,595
Cash flows used in investing activities | (1,213,992) | (1,481,493) | (909,401)
Cash flows from (used in) financing activities | 282,383 | 66,261 | (2,002,969)
Unallocated amounts | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets | (639) | (202) | (3,369)
Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 941,940 | 913,912 | 1,172,334
Cost of sales | (775,152) | (691,509) | (722,261)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (72,211) | (70,342) | (63,321)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 166,788 | 222,403 | 450,073
Income tax benefit (expense) | 0 | 0 | 0
Net income | 166,788 | 222,403 | 450,073
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Specialty plant nutrients | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 968,312 | 892,151 | 754,339
Cost of sales | (444,904) | (355,717) | (282,100)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (57,038) | (53,140) | (53,734)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 523,408 | 536,434 | 472,239
Income tax benefit (expense) | 0 | 0 | 0
Net income | 523,408 | 536,434 | 472,239
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Iodine and its derivatives | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 2,241,250 | 5,180,114 | 8,152,939
Cost of sales | (1,666,328) | (2,955,669) | (3,636,852)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (187,538) | (124,010) | (88,510)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 574,922 | 2,224,445 | 4,516,087
Income tax benefit (expense) | 0 | 0 | 0
Net income | 574,922 | 2,224,445 | 4,516,087
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Lithium and its derivatives | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 78,155 | 175,223 | 165,200
Cost of sales | (47,453) | (141,351) | (112,247)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (6,328) | (15,232) | (14,724)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 30,702 | 33,872 | 52,953
Income tax benefit (expense) | 0 | 0 | 0
Net income | 30,702 | 33,872 | 52,953
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Industrial chemicals | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 270,783 | 279,050 | 437,180
Cost of sales | (236,390) | (219,597) | (193,581)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (19,275) | (18,006) | (24,043)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 34,393 | 59,453 | 243,599
Income tax benefit (expense) | 0 | 0 | 0
Net income | 34,393 | 59,453 | 243,599
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Potassium | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 28,321 | 27,040 | 28,586
Cost of sales | (31,427) | (28,593) | (26,912)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (34) | (57) | (126)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | (3,106) | (1,553) | 1,674
Income tax benefit (expense) | 0 | 0 | 0
Net income | (3,106) | (1,553) | 1,674
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Other products and services | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets |  |  |
Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 4,528,761 | 7,467,490 | 10,710,578
Cost of sales | (3,201,654) | (4,392,436) | (4,973,953)
Administrative expenses | 0 | 0 | 0
Finance expense | 0 | 0 | 0
Depreciation and amortization expense | (342,424) | (280,787) | (244,458)
Interest in the income of associates and joint ventures accounted for by the equity method | 0 | 0 | 0
Income before taxes | 1,327,107 | 3,075,054 | 5,736,625
Income tax benefit (expense) | 0 | 0 | 0
Net income | 1,327,107 | 3,075,054 | 5,736,625
Assets | 0 | 0 | 0
Investment accounted for under the equity method | 0 | 0 | 0
Incorporation of non-current assets other than financial instruments, deferred tax assets, net defined benefit assets and rights arising from insurance contracts | 0 | 0 | 0
Other Liabilities | 0 | 0 | 0
Impairment loss of non-financial assets recognized in income | 0 | 0 | 0
Cash flows from (used in) operating activities | 0 | 0 | 0
Cash flows used in investing activities | 0 | 0 | 0
Cash flows from (used in) financing activities | 0 | 0 | 0
Reportable segments | Impairment provision for doubtful receivables |  |  |
Disclosure of operating segments [line items] |  |  |
Financial Assets | 0 | 0 | 0
Parent |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 4,528,761 |  | 10,710,578
Assets | 9,794,433 | 8,824,362 |
Other Liabilities | 4,633,614 | 4,383,163 |
Parent | Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 4,528,761 | 7,467,490 | 10,710,578
Parent | Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Parent | Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 941,940 | 913,912 | 1,172,334
Parent | Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 968,312 | 892,151 | 754,339
Parent | Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 2,241,250 | 5,180,114 | 8,152,939
Parent | Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 78,155 | 175,223 | 165,200
Parent | Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 270,783 | 279,050 | 437,180
Parent | Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 28,321 | 27,040 | 28,586
Parent | Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 4,528,761 | 7,467,490 | 10,710,578
Other Operating Segment |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Operating segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Unallocated amounts |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Specialty plant nutrients |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Iodine and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Lithium and its derivatives |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Industrial chemicals |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Potassium |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Other products and services |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | 0 | 0 | 0
Other Operating Segment | Reportable segments |  |  |
Disclosure of operating segments [line items] |  |  |
Revenue | $ 0 | $ 0 | $ 0

X
- Definition The amount of expenses that the entity classifies as being administrative. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2024-01-01 -Paragraph 35 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_vi&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_AdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_c&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_Assets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_CashFlowsFromUsedInFinancingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_CashFlowsFromUsedInInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities, from continuing and discontinued operations. [Refer: Revenue] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_10&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 50 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_50_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_CashFlowsFromUsedInOperatingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_CostOfSales
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of depreciation and amortisation expense. Depreciation and amortisation are the systematic allocations of depreciable amounts of assets over their useful lives. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_e&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B13 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_d&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 99 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_99&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 104 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_104&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_DepreciationAndAmortisationExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfOperatingSegmentsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of costs associated with financing activities of the entity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinanceCosts
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity’s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity’s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity’s own equity instruments. For this purpose the entity’s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity’s own equity instruments. [Refer: Classes of financial instruments [domain]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_25&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35H -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35H&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35M -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35M&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35N -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35N&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2024-01-01 -Paragraph 35I -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2024-en-r&anchor=para_35I&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_FinancialAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -Subparagraph h -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_h&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 26 -IssueDate 2024-01-01 -Paragraph 35 -Subparagraph b -Clause viii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2024-en-r&anchor=para_35_b_viii&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2024-01-01 -Paragraph 79 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_79&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2024-01-01 -Paragraph 81 -Subparagraph c -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_i&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 12 -IssueDate 2024-01-01 -Paragraph 81 -Subparagraph c -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2024-en-r&anchor=para_81_c_ii&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B13 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_IncomeTaxExpenseContinuingOperations
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 24 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_24_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B16 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B16&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 54 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_54_e&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_InvestmentAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_e&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_d&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Paragraph 93 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&anchor=para_93_b&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_55&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_Liabilities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 7 -IssueDate 2024-01-01 -Paragraph 18 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2024-en-r&anchor=para_18_b&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 32 -Subparagraph a -Clause ii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_32_a_ii&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 1 -IssueDate 2024-01-01 -Paragraph 24 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2024-en-r&anchor=para_24_b&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 17 -IssueDate 2024-01-01 -Paragraph 113 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2024-en-r&anchor=para_113_b&doctype=Standard -URIDate 2024-03-27 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 81A -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_81A_a&doctype=Standard -URIDate 2024-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 106 -Subparagraph d -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_106_d_i&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProfitLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_b&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2024-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ProfitLossBeforeTax
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_a&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_a&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 32 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_32&doctype=Standard -URIDate 2024-03-27 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 33 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_33_a&doctype=Standard -URIDate 2024-03-27 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 34 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_34&doctype=Standard -URIDate 2024-03-27 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 5 -IssueDate 2024-01-01 -Paragraph 33 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2024-en-r&anchor=para_33_b_i&doctype=Standard -URIDate 2024-03-27 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B12 -Subparagraph b -Clause v -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 12 -IssueDate 2024-01-01 -Paragraph B10 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2024-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B -URIDate 2024-03-27 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_a&doctype=Standard -URIDate 2024-03-27 Reference 10: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 103 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_103&doctype=Standard -URIDate 2024-03-27 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 102 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_102&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_Revenue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Total for all joint ventures [member]; Profit (loss)] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 28 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_28_e&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 8 -IssueDate 2024-01-01 -Paragraph 23 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&anchor=para_23_g&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 82 -Subparagraph c -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_82_c&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Impairment loss of non-financial assets + References No definition available. + Details
Name: | sqm_ImpairmentLossOfNonFinancialAssets
Namespace Prefix: | sqm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Incorporation of noncurrent assets other than financial instruments , deferred tax assets, net defined benefit assets and rights arising from insurance contracts + References No definition available. + Details
Name: | sqm_IncorporationOfNonCurrentAssetsOtherThanFinancialInstruments
Namespace Prefix: | sqm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_UnallocatedAmountsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_SpecialtyPlantNutrientsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IodineAndItsDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_LithiumAndItsDerivativesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_IndustrialChemicalsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_PotassiumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ProductsAndServicesAxis=sqm_OtherProductsAndServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_ParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=sqm_OtherOperatingSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |